308 related articles for article (PubMed ID: 14530217)
1. Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor.
Wen LT; Knowles AF
Br J Pharmacol; 2003 Nov; 140(6):1009-18. PubMed ID: 14530217
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism of vasoregulation: ADP-induced relaxation of the porcine isolated coronary artery is mediated via adenosine release.
Rayment SJ; Ralevic V; Barrett DA; Cordell R; Alexander SP
FASEB J; 2007 Feb; 21(2):577-85. PubMed ID: 17167068
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase activation and changes in Bax protein expression associated with extracellular ATP-mediated apoptosis in human embryonic kidney 293-P2X7 cells.
Wen LT; Caldwell CC; Knowles AF
Mol Pharmacol; 2003 Mar; 63(3):706-13. PubMed ID: 12606781
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of adenosine-induced apoptosis in human HepG2 cells.
Wu LF; Li GP; Feng JL; Pu ZJ
Acta Pharmacol Sin; 2006 Apr; 27(4):477-84. PubMed ID: 16539849
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of HL-60 cells by extracellular ATP: concentration-dependent involvement of a P2 receptor and adenosine generation.
Seetulsingh-Goorah SP; Stewart BW
Biochem Biophys Res Commun; 1998 Sep; 250(2):390-6. PubMed ID: 9753640
[TBL] [Abstract][Full Text] [Related]
6. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors.
Chen Y; Shukla A; Namiki S; Insel PA; Junger WG
J Leukoc Biol; 2004 Jul; 76(1):245-53. PubMed ID: 15107462
[TBL] [Abstract][Full Text] [Related]
7. Adenosine-induced apoptosis in EL-4 thymoma cells is caspase-independent and mediated through a non-classical adenosine receptor.
El-Darahali A; Fawcett H; Mader JS; Conrad DM; Hoskin DW
Exp Mol Pathol; 2005 Dec; 79(3):249-58. PubMed ID: 16168410
[TBL] [Abstract][Full Text] [Related]
8. Expression of functional P2-purinergic receptors in primary cultures of human colorectal carcinoma cells.
Höpfner M; Lemmer K; Jansen A; Hanski C; Riecken EO; Gavish M; Mann B; Buhr H; Glassmeier G; Scherübl H
Biochem Biophys Res Commun; 1998 Oct; 251(3):811-7. PubMed ID: 9790992
[TBL] [Abstract][Full Text] [Related]
9. Separate P2T and P2U purinergic receptors with similar second messenger signaling pathways in UMR-106 osteoblasts.
Sistare FD; Rosenzweig BA; Contrera JG; Jordan B
J Pharmacol Exp Ther; 1994 Jun; 269(3):1049-61. PubMed ID: 8014849
[TBL] [Abstract][Full Text] [Related]
10. P2Z/P2X7 receptor-dependent apoptosis of dendritic cells.
Coutinho-Silva R; Persechini PM; Bisaggio RD; Perfettini JL; Neto AC; Kanellopoulos JM; Motta-Ly I; Dautry-Varsat A; Ojcius DM
Am J Physiol; 1999 May; 276(5):C1139-47. PubMed ID: 10329963
[TBL] [Abstract][Full Text] [Related]
11. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer.
Shabbir M; Ryten M; Thompson C; Mikhailidis D; Burnstock G
BJU Int; 2008 Feb; 101(3):352-9. PubMed ID: 18005209
[TBL] [Abstract][Full Text] [Related]
12. Cell death induced by uridine 5'-triphosphate (UTP) in contrast to adenosine 5'-triphosphate (ATP) in human epidermoid carcinoma cells (A-431).
Völkl T; Ogilvie A; Neuhuber W; Ogilvie A
Cell Physiol Biochem; 2008; 22(5-6):441-54. PubMed ID: 19088426
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
14. Extracellular ATP triggers cyclic AMP-dependent differentiation of HL-60 cells.
Jiang L; Foster FM; Ward P; Tasevski V; Luttrell BM; Conigrave AD
Biochem Biophys Res Commun; 1997 Mar; 232(3):626-30. PubMed ID: 9126325
[TBL] [Abstract][Full Text] [Related]
15. P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors.
Conigrave AD; Fernando KC; Gu B; Tasevski V; Zhang W; Luttrell BM; Wiley JS
Eur J Pharmacol; 2001 Aug; 426(3):157-63. PubMed ID: 11527539
[TBL] [Abstract][Full Text] [Related]
16. Expression of a P2X7 receptor by a subpopulation of human osteoblasts.
Gartland A; Hipskind RA; Gallagher JA; Bowler WB
J Bone Miner Res; 2001 May; 16(5):846-56. PubMed ID: 11341329
[TBL] [Abstract][Full Text] [Related]
17. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling.
Hoebertz A; Mahendran S; Burnstock G; Arnett TR
J Cell Biochem; 2002; 86(3):413-9. PubMed ID: 12210747
[TBL] [Abstract][Full Text] [Related]
18. Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release.
Koolpe M; Pearson D; Benton HP
Arthritis Rheum; 1999 Feb; 42(2):258-67. PubMed ID: 10025919
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibitory effect and apoptosis induced by extracellular ATP and adenosine on human gastric carcinoma cells: involvement of intracellular uptake of adenosine.
Wang MX; Ren LM
Acta Pharmacol Sin; 2006 Aug; 27(8):1085-92. PubMed ID: 16867263
[TBL] [Abstract][Full Text] [Related]
20. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
